Pilot Study of Reparixin for Early Allograft Dysfunction Prevention in Liver Transplantation
Clinical trial NCT03031470 · TERMINATED
Trial details
- NCT number
- NCT03031470
- Sponsor
- Dompé Farmaceutici S.p.A
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-10
- Primary completion
- 2017-02-09
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.